Desmond Curran, Desirée Van Oorschot, Sean Matthews, Johannes Hain, Ahmed Ehab Salem, & Magdalena Schwarz. (2021). Long-term efficacy data for the recombinant zoster vaccine: Impact on public health and cost effectiveness in Germany. Taylor & Francis Group.
Chicago Style (17th ed.) CitationDesmond Curran, Desirée Van Oorschot, Sean Matthews, Johannes Hain, Ahmed Ehab Salem, and Magdalena Schwarz. Long-term Efficacy Data for the Recombinant Zoster Vaccine: Impact on Public Health and Cost Effectiveness in Germany. Taylor & Francis Group, 2021.
MLA (9th ed.) CitationDesmond Curran, et al. Long-term Efficacy Data for the Recombinant Zoster Vaccine: Impact on Public Health and Cost Effectiveness in Germany. Taylor & Francis Group, 2021.
Warning: These citations may not always be 100% accurate.